Page last updated: 2024-12-10

5-methoxypodophyllotoxin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

5-methoxypodophyllotoxin: from root culture of Linum flavum; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

FloraRankFlora DefinitionFamilyFamily Definition
Linumgenus[no description available]LinaceaeA plant family in the order Linales. These plants have simple leaves and regular flowers housing a compound ovary. Stamens are usually fused by their filaments.[MeSH]

Cross-References

ID SourceID
PubMed CID3035544
CHEMBL ID292945
CHEBI ID188507
MeSH IDM0202191

Synonyms (12)

Synonym
5-methoxypodophyllotoxin
6-methoxypodophyllotoxin
CHEMBL292945
5-methoxy podophyllotoxin
(5r,5ar,8ar,9r)-5-hydroxy-4-methoxy-9-(3,4,5-trimethoxyphenyl)-5a,6,8a,9-tetrahydro-5h-[2]benzofuro[6,5-f][1,3]benzodioxol-8-one
CHEBI:188507
(5r,5ar,8ar,9r)-5-hydroxy-4-methoxy-9-(3,4,5-trimethoxyphenyl)-5a,6,8a,9-tetrahydro-5h-[2]benzouro[6,5-][1,3]benzodioxol-8-one
128443-52-7
(5r-(5alpha,5abeta,8aalpha,9alpha))-5,8,8a,9-tetrahydro-9-hydroxy-10-methoxy-5-(3,4,5-trimethoxyphenyl)furo(3',4':6,7)naphtho(2,3-d)-1,3-dioxol-6(5ah)-one
furo(3',4':6,7)naphtho(2,3-d)-1,3-dioxol-6(5ah)-one, 5,8,8a,9-tetrahydro-9-hydroxy-10-methoxy-5-(3,4,5-trimethoxyphenyl)-, (5r-(5alpha,5abeta,8aalpha,9alpha))-
DTXSID00155903
Q63398578
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
furonaphthodioxole
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (2)

PathwayProteinsCompounds
podophyllotoxin glucosides metabolism014
6-methoxypodophyllotoxin biosynthesis014
podophyllotoxin glucosides metabolism017

Bioassays (6)

Assay IDTitleYearJournalArticle
AID311265Cytotoxicity against human KB cells by microculture tetrazolium assay2007Journal of natural products, Aug, Volume: 70, Issue:8
Sesquiterpenoids and cytotoxic lignans from the bark of Libocedrus chevalieri.
AID73177Cytotoxic effect against GLC4 (human small cell lung carcinoma cell line) using the microculture tetrazolium (MTT) assay based on 2 hr incubation1995Journal of medicinal chemistry, Jun-09, Volume: 38, Issue:12
Synthesis and cytotoxicity of novel lignans.
AID338804Cytotoxicity against mouse EAT cells after 4 days by trypan blue assay1992Journal of natural products, Jan, Volume: 55, Issue:1
Isolation, purification, and cytotoxicity of 5-methoxypodophyllotoxin, a lignan from a root culture of Linum flavum.
AID311266Inhibition of tubulin polymerization2007Journal of natural products, Aug, Volume: 70, Issue:8
Sesquiterpenoids and cytotoxic lignans from the bark of Libocedrus chevalieri.
AID338805Cytotoxicity against human HeLa cells after 4 days by trypan blue assay1992Journal of natural products, Jan, Volume: 55, Issue:1
Isolation, purification, and cytotoxicity of 5-methoxypodophyllotoxin, a lignan from a root culture of Linum flavum.
AID73178Cytotoxic effect against GLC4 (human small cell lung carcinoma cell line) using the microculture tetrazolium (MTT) assay based on continuous incubation1995Journal of medicinal chemistry, Jun-09, Volume: 38, Issue:12
Synthesis and cytotoxicity of novel lignans.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (9)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's2 (22.22)18.2507
2000's6 (66.67)29.6817
2010's1 (11.11)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.14

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.14 (24.57)
Research Supply Index2.48 (2.92)
Research Growth Index4.63 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.14)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other11 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]